Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation (Details)

v3.23.2
Stock Based Compensation (Details)
 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Stock Based Compensation  
Number of shares, Beginning balance | shares 18,876,912
Number of shares, Grants | shares 500,000
Number of shares, Expirations | shares (137,241)
Number of shares, Exercised | shares (1,545,467)
Number of shares, Ending balance | shares 17,694,204
Options exercisable, Ending balance | shares 17,194,204
Weighted Average Exercise Price, Beginning balance | $ / shares $ 0.50
Weighted Average Exercise Price, Grants | $ / shares 0.40
Weighted Average Exercise Price, Expirations | $ / shares 0.26
Weighted Average Exercise Price, Exercised | $ / shares 0.25
Weighted Average Exercise Price, Ending balance | $ / shares 0.52
Weighted Average Exercise Price exercisable, Ending balance | $ / shares $ 0.53
Weighted Average Remaining Contractual Life (years), Beginning balance 2 years 3 months 21 days
Weighted Average Remaining Contractual Life (years), Ending balance 2 years 25 days
Weighted Average Remaining Contractual Life exercisable, Ending balance 1 year 10 months 28 days
Aggregate Intrinsic Value, Beginning balance | $ $ 246,666
Aggregate Intrinsic Value, Ending balance | $ 370,447
Options exercisable, Ending balance, Intrinsic value | $ $ 370,447